Event

Early use of high-efficacy therapies in people with MS: What is holding us back?

Webinar New

22 Jun 2022 12:00 - 13:30

Please note that all session and slide content are the views of the Speakers, not the MS Academy. The content of the recording is the speaker’s personal opinion at the time of recording. Due to the everchanging situation, advice given at the time of recording is subject to change.

Join us for an honest discussion looking at the latest evidence for early, intensive treatment of MS –Safety of high-efficacy DMTs: has COVID-19 changed things? How can MS services cope with widespread use of high-efficacy therapies and what are the barriers to early use of high efficacy disease modify therapy

Objectives:

  • Provide evidence for and safety of high efficacy treatments.
  • Identify barriers to early use of high efficacy therapies - including unit capacity & availability of screening OPAs. strategies to overcome these? eg data collection / business cases
  • Discussions around how can we plan for the widespread use of high-efficacy therapies in MS

CPD accreditation

Early use of high-efficacy therapies in people with MS: What is holding us back? has been approved by the Federation of the Royal Colleges of Physicians of the United Kingdom for 1 category 1 (external) CPD credit(s).

Please note CPD does not include satellite symposia sessions.

Dr David Paling - presentation slides

Aoife Shields - presentation slides

Carolyn Cairns - presentation slides

Were you registered on this course?

Log in to access resources..

Login
Our sponsor
Novartis logo

This activity has been supported by sponsorship from Novartis Pharmaceuticals UK Limited. The sponsor has had no control over the educational content of this activity.

Encouraging excellence, developing leaders, inspiring change

MS Academy was established five years ago and in that time has accomplished a huge amount. The six different levels of specialist MS training are dedicated to case-based learning and practical application of cutting edge research. Home to national programme Raising the Bar and the fantastic workstream content it is producing, this is an exciting Academy to belong to.